Suppr超能文献

脂联素 45T/G 多态性与韩国 2 型糖尿病患者心血管并发症的关系。

Association of Adiponectin 45T/G Polymorphism with Diabetic Cardiovascular Complications in Korean Type 2 Diabetes.

机构信息

Department of Internal Medicine, SynWoo Hospital, Seongnam, Korea.

Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju, Korea.

出版信息

J Korean Med Sci. 2018 Apr 3;33(17):e124. doi: 10.3346/jkms.2018.33.e124. eCollection 2018 Apr 23.

Abstract

BACKGROUND

Adiponectin is an adipokine that regulates lipid and glucose metabolism and has been shown to have anti-inflammatory and anti-atherogenic effects. It also plays an important role in the development of cardiovascular disease (CVD).

METHODS

This study evaluated the association between adiponectin 45T/G polymorphism and cardiovascular complication in type 2 diabetes in Koreans.

RESULTS

The present study included 758 patients with type 2 diabetes. The distribution of the adiponectin 45T/G polymorphism was 3.56% (n = 27) for GG, 42.35% (n = 321) for TG, and 54.09% (n = 410) for TT in patients with type 2 diabetes. The prevalence of CVD was significantly higher in subjects with the GG + TG genotype compared to those with the TT genotype (17.5% vs. 9.8%, = 0.002). The G allele was associated with a higher risk of CVD ( = 0.002).

CONCLUSION

Our findings suggest that the adiponectin 45T/G polymorphism is associated with diabetic cardiovascular complication in type 2 diabetes.

摘要

背景

脂联素是一种调节脂质和葡萄糖代谢的脂肪因子,具有抗炎和抗动脉粥样硬化作用。它在心血管疾病(CVD)的发展中也起着重要作用。

方法

本研究评估了韩国 2 型糖尿病患者脂联素 45T/G 多态性与心血管并发症的关系。

结果

本研究共纳入 758 例 2 型糖尿病患者。脂联素 45T/G 多态性在 2 型糖尿病患者中的分布为 GG 基因型占 3.56%(n=27),TG 基因型占 42.35%(n=321),TT 基因型占 54.09%(n=410)。与 TT 基因型相比,GG+TG 基因型患者 CVD 的患病率明显更高(17.5% vs. 9.8%, = 0.002)。G 等位基因与 CVD 的风险增加相关( = 0.002)。

结论

我们的研究结果表明,脂联素 45T/G 多态性与 2 型糖尿病的糖尿病心血管并发症有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a24/5909101/c200e62a130f/jkms-33-e124-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验